Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
3.80   -0.21 (5.24%)  3.80 - 4.08  8,367,300
Trade this stock with 3 x trading limit. Find out more.

Financials


Market Cap: 2,683 Million

Market Cap 2,683 Million
NOSH 706 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 30-Apr-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 30-Apr-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Jun-2020 [#2]

Latest Quarter: 30-Jun-2020 [#2]
Announcement Date 13-Aug-2020
Next Quarter: 30-Sep-2020
Est. Ann. Date: 29-Nov-2020
Est. Ann. Due Date: 29-Nov-2020
QoQ | YoY   8.61%  |    5.84%

Annual (Unaudited) ( EPS: 7.83, P/E: 48.54 )

Revenue | NP to SH 576,462  |  55,273
RPS | P/RPS 81.65 Cent  |  4.65
EPS | P/E | EY 7.83 Cent  |  48.54  |  2.06%
DPS | DY | Payout % 5.80 Cent  |  1.53%  |  74.06%
NAPS | P/NAPS 0.74  |  5.11
YoY   16.02%
NP Margin | ROE 9.59%  |  10.52%
F.Y. | Ann. Date 31-Dec-2019  |  13-Feb-2020

T4Q Result ( EPS: 7.82, P/E: 48.62 )

Revenue | NP to SH 582,654  |  55,182
RPS | P/RPS 82.53 Cent  |  4.60
EPS | P/E | EY 7.82 Cent  |  48.62  |  2.06%
DPS | DY | Payout % 5.32 Cent  |  1.40%  |  68.02%
NAPS | P/NAPS 0.82  |  4.61
QoQ | YoY   1.50%  |    0.27%
NP Margin | ROE 9.47%  |  9.49%
F.Y. | Ann. Date 30-Jun-2020  |  13-Aug-2020

Annualized Result ( EPS: 8.01, P/E: 47.42 )

Revenue | NP to SH 604,088  |  56,580
RPS | P/RPS 85.56 Cent  |  4.44
EPS | P/E | EY 8.01 Cent  |  47.42  |  2.11%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   4.31%  |    -0.32%
NP Margin | ROE 9.37%  |  9.73%
F.Y. | Ann. Date 30-Jun-2020  |  13-Aug-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2020 13-Aug-2020 30-Jun-2020 2 582,654 70,825 55,182 55,182 37,536 581,725 68.02% 9.47% 9.49% 684,383 85.14 82.53 8.06 7.82 5.50 5.32 0.8500 0.82   1.50%   0.27% 30-Jun-2020 1.62 1.90 20.09 1.91 4.98% 3.40% 13-Aug-2020 3.15 3.70 39.07 3.71 2.56% 1.75%
31-Dec-2020 18-May-2020 31-Mar-2020 1 584,789 69,750 54,369 54,369 40,733 540,662 74.92% 9.30% 10.06% 684,383 85.45 82.83 7.94 7.70 5.95 5.77 0.7900 0.77   -1.64%   5.65% 31-Mar-2020 1.39 1.63 17.50 1.76 5.72% 4.28% 18-May-2020 1.72 2.01 21.65 2.18 4.62% 3.46%
31-Dec-2019 13-Feb-2020 31-Dec-2019 4 576,462 70,809 55,273 55,273 40,733 525,364 73.69% 9.59% 10.52% 682,292 84.49 81.65 8.10 7.83 5.97 5.77 0.7700 0.74   -4.05%   15.69% 31-Dec-2019 1.42 1.68 17.53 1.84 5.70% 4.20% 13-Feb-2020 1.64 1.94 20.24 2.13 4.94% 3.64%
31-Dec-2019 29-Nov-2019 30-Sep-2019 3 554,341 74,528 57,609 57,609 33,094 505,919 57.45% 10.39% 11.39% 674,559 82.18 78.52 8.54 8.16 5.00 4.69 0.7500 0.72   4.68%   27.24% 30-Sep-2019 1.40 1.70 16.39 1.87 6.10% 3.57% 29-Nov-2019 1.39 1.69 16.28 1.85 6.14% 3.60%
31-Dec-2019 30-Aug-2019 30-Jun-2019 2 537,324 70,598 55,036 55,036 33,094 503,029 60.13% 10.24% 10.94% 661,881 81.18 76.11 8.32 7.80 5.00 4.69 0.7600 0.71   6.95%   23.97% 28-Jun-2019 1.37 1.69 16.48 1.80 6.07% 3.65% 30-Aug-2019 1.41 1.74 16.96 1.86 5.90% 3.55%
31-Dec-2019 21-May-2019 31-Mar-2019 1 515,849 65,197 51,459 51,459 30,674 496,410 59.61% 9.98% 10.37% 661,881 77.94 73.06 7.77 7.29 4.63 4.34 0.7500 0.70   7.71%   17.73% 29-Mar-2019 1.28 1.64 16.46 1.71 6.07% 3.62% 21-May-2019 1.36 1.75 17.49 1.81 5.72% 3.41%
31-Dec-2018 18-Feb-2019 31-Dec-2018 4 498,722 59,666 47,641 47,776 30,674 483,173 64.21% 9.55% 9.89% 661,881 75.35 70.64 7.22 6.77 4.63 4.34 0.7300 0.68   5.52%   12.44% 31-Dec-2018 0.95 1.26 13.16 1.30 7.60% 4.88% 18-Feb-2019 1.03 1.37 14.27 1.41 7.01% 4.50%
31-Dec-2018 28-Nov-2018 30-Sep-2018 3 495,341 54,833 45,040 45,277 20,937 501,487 46.24% 9.09% 9.03% 659,852 75.07 70.16 6.86 6.41 3.17 2.97 0.7600 0.71   1.98%   11.66% 28-Sep-2018 1.23 1.64 17.93 1.62 5.58% 2.58% 28-Nov-2018 1.07 1.43 15.59 1.41 6.41% 2.97%
31-Dec-2018 26-Nov-2018 30-Jun-2018 2 484,882 53,202 43,881 44,396 20,937 209,983 47.16% 9.05% 21.14% 279,978 173.19 68.68 15.86 6.29 7.50 2.97 0.7500 0.30   1.57%   25.12% 29-Jun-2018 1.30 0.75 8.20 1.73 12.20% 5.77% 26-Nov-2018 1.08 0.62 6.81 1.44 14.68% 6.94%
31-Dec-2018 28-May-2018 31-Mar-2018 1 477,940 52,929 43,183 43,710 23,711 206,429 54.25% 9.04% 21.17% 278,959 171.33 67.69 15.67 6.19 8.50 3.36 0.7400 0.29   2.87%   56.72% 30-Mar-2018 2.80 1.63 17.87 3.78 5.60% 3.04% 28-May-2018 3.35 1.96 21.38 4.53 4.68% 2.54%
31-Dec-2017 28-Feb-2018 31-Dec-2017 4 467,987 51,796 42,100 42,492 23,711 479,809 55.80% 9.00% 8.86% 278,959 167.76 66.28 15.23 6.02 8.50 3.36 1.7200 0.68   4.79%   56.71% 29-Dec-2017 2.53 1.51 16.61 1.47 6.02% 3.36% 28-Feb-2018 2.97 1.77 19.50 1.73 5.13% 2.86%
31-Dec-2017 17-Nov-2017 30-Sep-2017 3 429,767 45,270 39,854 40,548 7,085 474,230 17.47% 9.27% 8.55% 278,959 154.06 60.87 14.54 5.74 2.54 1.00 1.7000 0.67   14.27%   19.18% 29-Sep-2017 2.20 1.43 15.14 1.29 6.61% 1.15% 17-Nov-2017 2.20 1.43 15.14 1.29 6.61% 1.15%
31-Dec-2017 25-Aug-2017 30-Jun-2017 2 394,690 38,579 34,953 35,484 7,085 463,071 19.97% 8.86% 7.66% 278,959 141.49 55.90 12.72 5.03 2.54 1.00 1.6600 0.66   27.23%   -2.29% 30-Jun-2017 2.25 1.59 17.69 1.36 5.65% 1.13% 25-Aug-2017 2.03 1.43 15.96 1.22 6.27% 1.25%
31-Dec-2017 22-May-2017 31-Mar-2017 1 354,464 32,714 27,616 27,890 19,142 463,071 68.64% 7.79% 6.02% 278,959 127.07 50.21 10.00 3.95 6.86 2.71 1.6600 0.66   2.86%   -25.94% 31-Mar-2017 2.31 1.82 23.10 1.39 4.33% 2.97% 22-May-2017 2.32 1.83 23.20 1.40 4.31% 2.96%
31-Dec-2016 24-Feb-2017 31-Dec-2016 4 312,940 31,479 26,826 27,115 19,142 454,703 70.60% 8.57% 5.96% 278,959 112.18 44.32 9.72 3.84 6.86 2.71 1.6300 0.64   -20.30%   -30.09% 30-Dec-2016 1.98 1.76 20.37 1.21 4.91% 3.47% 24-Feb-2017 2.23 1.99 22.94 1.37 4.36% 3.08%
31-Dec-2016 21-Nov-2016 30-Sep-2016 3 328,308 42,709 33,330 34,022 8,084 451,913 23.76% 10.15% 7.53% 278,959 117.69 46.50 12.20 4.82 2.90 1.15 1.6200 0.64   -6.31%   -1.58% 30-Sep-2016 2.06 1.75 16.89 1.27 5.92% 1.41% 21-Nov-2016 2.10 1.78 17.22 1.30 5.81% 1.38%
31-Dec-2016 22-Aug-2016 30-Jun-2016 2 327,738 46,824 35,737 36,314 8,084 510,978 22.26% 10.90% 7.11% 319,361 102.62 46.42 11.37 5.14 2.53 1.15 1.6000 0.72   -3.57%   4.90% 30-Jun-2016 2.04 1.99 17.94 1.28 5.57% 1.24% 22-Aug-2016 2.14 2.09 18.82 1.34 5.31% 1.18%
31-Dec-2016 18-May-2016 31-Mar-2016 1 304,911 47,508 37,644 37,659 5,682 457,740 15.09% 12.35% 8.23% 279,110 109.24 43.19 13.49 5.33 2.04 0.80 1.6400 0.65   -2.90%   3.79% 31-Mar-2016 2.55 2.33 18.90 1.55 5.29% 0.80% 18-May-2016 2.40 2.20 17.79 1.46 5.62% 0.85%
31-Dec-2015 23-Feb-2016 31-Dec-2015 4 271,040 49,765 38,785 38,785 5,682 270,323 14.65% 14.31% 14.35% 166,866 162.43 38.39 23.24 5.49 3.41 0.80 1.6200 0.38   12.20%   8.71% 31-Dec-2015 2.62 1.61 11.27 1.62 8.87% 1.30% 23-Feb-2016 2.61 1.61 11.23 1.61 8.91% 1.30%
31-Dec-2015 24-Nov-2015 30-Sep-2015 3 232,663 46,157 37,371 34,569 25,710 268,530 74.38% 16.06% 12.87% 166,789 139.50 32.95 20.73 4.90 15.42 3.64 1.6100 0.38   -0.14%   2.05% 30-Sep-2015 2.72 1.95 13.12 1.69 7.62% 5.67% 24-Nov-2015 2.70 1.94 13.03 1.68 7.68% 5.71%
31-Dec-2015 25-Aug-2015 30-Jun-2015 2 197,750 45,813 37,420 34,618 25,710 189,815 74.27% 18.92% 18.24% 139,570 141.68 28.01 24.80 4.90 18.50 3.64 1.3600 0.27   -4.59%   8.26% 30-Jun-2015 2.65 1.87 10.68 1.95 9.36% 6.98% 25-Aug-2015 2.40 1.69 9.68 1.76 10.33% 7.71%
31-Dec-2015 18-May-2015 31-Mar-2015 1 182,065 47,513 39,085 36,283 25,682 205,045 70.79% 21.47% 17.70% 139,486 130.52 25.79 26.01 5.14 18.50 3.64 1.4700 0.29   1.69%   3.21% 31-Mar-2015 3.88 2.97 14.92 2.64 6.70% 4.77% 18-May-2015 3.90 2.99 14.99 2.65 6.67% 4.74%
31-Dec-2014 24-Feb-2015 31-Dec-2014 4 176,961 46,490 38,481 35,679 25,682 192,951 71.98% 21.75% 18.49% 138,813 127.48 25.06 25.70 5.05 18.50 3.64 1.3900 0.27   5.33%   6.55% 31-Dec-2014 2.50 1.96 9.73 1.80 10.28% 7.40% 24-Feb-2015 2.92 2.29 11.36 2.10 8.80% 6.34%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 171,671 41,729 33,873 33,873 24,291 187,531 71.71% 19.73% 18.06% 138,912 123.58 24.32 24.38 4.80 17.50 3.44 1.3500 0.27   5.93%   12.27% 30-Sep-2014 3.17 2.57 13.00 2.35 7.69% 5.52% 21-Nov-2014 3.01 2.44 12.34 2.23 8.10% 5.81%
31-Dec-2014 26-Aug-2014 30-Jun-2014 2 167,697 39,496 31,977 31,977 24,291 179,145 75.97% 19.07% 17.85% 138,872 120.76 23.75 23.03 4.53 17.50 3.44 1.2900 0.25   -9.03%   7.20% 30-Jun-2014 2.97 2.46 12.90 2.30 7.75% 5.89% 26-Aug-2014 3.37 2.79 14.64 2.61 6.83% 5.19%
31-Dec-2014 20-May-2014 31-Mar-2014 1 165,062 42,396 35,153 35,153 24,289 190,050 69.10% 21.30% 18.50% 138,723 118.99 23.38 25.34 4.98 17.50 3.44 1.3700 0.27   4.98%   35.17% 31-Mar-2014 3.03 2.55 11.96 2.21 8.36% 5.78% 20-May-2014 3.09 2.60 12.19 2.26 8.20% 5.66%
31-Dec-2013 26-Feb-2014 31-Dec-2013 4 162,404 40,177 33,487 33,487 24,289 181,818 72.53% 20.62% 18.42% 138,792 117.01 23.00 24.13 4.74 17.50 3.44 1.3100 0.26   10.99%   28.72% 31-Dec-2013 2.58 2.20 10.69 1.97 9.35% 6.78% 26-Feb-2014 2.60 2.22 10.78 1.98 9.28% 6.73%
31-Dec-2013 19-Nov-2013 30-Sep-2013 3 152,048 40,017 30,172 30,172 20,128 179,017 66.71% 19.84% 16.85% 138,773 109.57 21.54 21.74 4.27 14.50 2.85 1.2900 0.25   1.15%   14.52% 30-Sep-2013 2.55 2.33 11.73 1.98 8.53% 5.69% 19-Nov-2013 2.56 2.34 11.77 1.98 8.49% 5.66%
31-Dec-2013 28-Aug-2013 30-Jun-2013 2 140,724 39,354 29,828 29,828 20,128 187,404 67.48% 21.20% 15.92% 138,818 101.37 19.93 21.49 4.22 14.50 2.85 1.3500 0.27   14.70%   8.76% 28-Jun-2013 2.38 2.35 11.08 1.76 9.03% 6.09% 28-Aug-2013 2.44 2.41 11.36 1.81 8.81% 5.94%
31-Dec-2013 27-May-2013 31-Mar-2013 1 137,091 35,384 26,006 26,006 19,431 176,143 74.72% 18.97% 14.76% 138,695 98.84 19.42 18.75 3.68 14.00 2.75 1.2700 0.25   -0.03%   -5.40% 29-Mar-2013 2.23 2.26 11.89 1.76 8.41% 6.28% 27-May-2013 2.51 2.54 13.39 1.98 7.47% 5.58%
31-Dec-2012 25-Feb-2013 31-Dec-2012 4 135,311 35,297 26,015 26,015 19,431 169,359 74.69% 19.23% 15.36% 138,819 97.47 19.17 18.74 3.68 14.00 2.75 1.2200 0.24   -1.26%   -2.59% 31-Dec-2012 2.13 2.19 11.37 1.75 8.80% 6.57% 25-Feb-2013 2.17 2.23 11.58 1.78 8.64% 6.45%
31-Dec-2012 23-Nov-2012 30-Sep-2012 3 132,969 34,133 26,346 26,346 18,318 167,991 69.53% 19.81% 15.68% 138,836 95.77 18.83 18.98 3.73 13.20 2.59 1.2100 0.24   -3.93%   -9.12% 28-Sep-2012 2.36 2.46 12.44 1.95 8.04% 5.59% 23-Nov-2012 2.28 2.38 12.01 1.88 8.32% 5.79%
31-Dec-2012 16-Aug-2012 30-Jun-2012 2 140,215 35,468 27,425 27,425 24,980 162,310 91.09% 19.56% 16.90% 138,727 101.07 19.86 19.77 3.88 18.00 3.54 1.1700 0.23   -0.24%   -5.72% 29-Jun-2012 2.23 2.21 11.28 1.91 8.87% 8.07% 16-Aug-2012 2.38 2.35 12.04 2.03 8.31% 7.56%
31-Dec-2012 17-May-2012 31-Mar-2012 1 141,205 35,723 27,490 27,490 24,987 170,824 90.90% 19.47% 16.09% 138,881 101.67 20.00 19.79 3.89 18.00 3.54 1.2300 0.24   2.94%   -6.70% 30-Mar-2012 2.40 2.36 12.13 1.95 8.25% 7.50% 17-May-2012 2.38 2.34 12.02 1.93 8.32% 7.56%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 138,132 34,729 26,706 26,706 24,987 163,776 93.56% 19.33% 16.31% 138,793 99.52 19.56 19.24 3.78 18.00 3.54 1.1800 0.23   -7.88%   -6.85% 30-Dec-2011 2.02 2.03 10.50 1.71 9.53% 8.91% 22-Feb-2012 2.12 2.13 11.02 1.80 9.08% 8.49%
31-Dec-2011 21-Nov-2011 30-Sep-2011 3 137,291 35,500 28,991 28,991 5,014 162,353 17.30% 21.12% 17.86% 138,763 98.94 19.45 20.89 4.11 3.61 0.71 1.1700 0.23   -0.34%   3.91% 30-Sep-2011 2.10 2.12 10.05 1.79 9.95% 1.72% 21-Nov-2011 2.10 2.12 10.05 1.79 9.95% 1.72%
31-Dec-2011 18-Aug-2011 30-Jun-2011 2 134,988 35,995 29,089 29,089 5,014 154,198 17.24% 21.55% 18.86% 138,917 97.17 19.12 20.94 4.12 3.61 0.71 1.1100 0.22   -1.27%   6.91% 30-Jun-2011 2.34 2.41 11.17 2.11 8.95% 1.54% 18-Aug-2011 2.22 2.28 10.60 2.00 9.43% 1.63%
31-Dec-2011 25-May-2011 31-Mar-2011 1 135,625 36,493 29,463 29,463 6,402 162,320 21.73% 21.72% 18.15% 138,735 97.76 19.21 21.24 4.17 4.61 0.91 1.1700 0.23   2.77%   3.79% 31-Mar-2011 2.35 2.40 11.07 2.01 9.04% 1.96% 25-May-2011 2.57 2.63 12.10 2.20 8.26% 1.79%
31-Dec-2010 23-Feb-2011 31-Dec-2010 4 131,437 35,410 28,669 28,669 6,402 156,744 22.33% 21.81% 18.29% 138,711 94.76 18.62 20.67 4.06 4.61 0.91 1.1300 0.22   2.76%   -5.18% 30-Dec-2010 2.39 2.52 11.56 2.12 8.65% 1.93% 23-Feb-2011 2.45 2.59 11.85 2.17 8.44% 1.88%
31-Dec-2010 26-Nov-2010 30-Sep-2010 3 129,092 35,413 27,899 27,899 22,910 148,494 82.12% 21.61% 18.79% 138,779 93.02 18.28 20.10 3.95 16.50 3.24 1.0700 0.21   2.54%   7.69% 30-Sep-2010 2.44 2.62 12.14 2.28 8.24% 6.76% 26-Nov-2010 2.38 2.56 11.84 2.22 8.45% 6.93%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  8 people like this.
 
henry888 i don't trust any news from aljazeera. com. regarding China as she is pro US. Again, the president of Brazil's remarks in my opinion may be political in nature and also it is an internal affairs of the country in view of their financial constraints and the safety whether to use the vaccine. Is nothing to do with China vaccine.
22/10/2020 7:17 AM
Chrizleon19 The bull won’t be running yet. Trade accordingly to own discretion .
22/10/2020 7:25 AM
Keyman188 AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies

(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)

~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.

~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.


AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.

Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke. Shares were down by about 1% in early afternoon trading.

A spokesperson from AstraZeneca declined to comment on the volunteer, citing “medical confidentiality and clinical trial regulations.”

The spokesperson added that ”[a]ll significant medical events are carefully assessed by trial investigators” and ”[t]hese assessments have not led to any concerns about continuation of the ongoing study.”

In a statement, a spokesperson from the University of Oxford, which is developing the vaccine with AstraZeneca, said “there have been no concerns about safety of the clinical trial” after an assessment of the case in Brazil.

“The independent review in addition to the Brazilian regulator have recommended that the trial should continue,” Oxford spokesperson Alexander Buxton said.

Oxford provided no further details on the volunteer’s death, and it’s unclear if the volunteer received the vaccine. Brazil currently has the second deadliest outbreak in the world, behind the United States, with at least 115,914 deaths, according to data compiled by Johns Hopkins University.

A source familiar with the situation told Reuters that the trial would have been suspended if the volunteer had been a part of the group getting the shot.

The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States. That means the company is unable to administer second doses of its two-dose vaccine regimen to U.S. participants.

The company announced on Sept. 8 that its trial had been put on hold due to an unexplained illness in a patient in the United Kingdom. The patient is believed to have developed inflammation of the spinal cord, known as transverse myelitis. The trial has since resumed in the U.K. and other countries.

The U.S. is expected to resume the trial as early as this week after the FDA completed its review, Reuters reported Tuesday, citing four anonymous sources.

AstraZeneca is one of four drugmakers backed by the U.S. in late-stage testing for a potential vaccine. AstraZeneca’s vaccine, called AZD1222, uses genetic material from the coronavirus with a modified adenovirus.

In July, the company published data that showed its vaccine produced a promising immune response in an early-stage trial and appeared to be well tolerated.

The vaccine produced no serious adverse events in volunteers, according to the researchers at the time. Fatigue and headache were the most commonly reported side effects, they said. Other common side effects included pain at the injection site, muscle ache, chills and a fever.


##https://www.cnbc.com/2020/10/21/astrazeneca-shares-slide-after-brazilian-health-authority-says-volunteer-in-covid-vaccine-study-dies.html
22/10/2020 8:26 AM
Plantermen China vaccine strongly tipped to be Malaysia choice. Indonesia already pre book with China state owned lab
22/10/2020 8:28 AM
Keyman188 R.I.P....to heard that...

AstraZeneca's vaccine still not yet reach the safety consumption level...




Posted by Keyman188 > Oct 22, 2020 8:26 AM | Report Abuse X

AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies

(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)

~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.

~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.
22/10/2020 8:44 AM
yongyong88 big funds and insiders are buying. Swim with the big boys...
22/10/2020 8:50 AM
face All Vaccines related counter limit down...??
All Vaccines related counter limit down...??
https://edition.cnn.com/2020/10/21/health/covid-19-vaccine-trial-brazil-astrazeneca-death-bn/index.html
22/10/2020 8:51 AM
yongyong88 hope all vaccine stocks can limit down so can collect more. and ...more.let's pray n wait
22/10/2020 8:54 AM
yongyong88 waiting for limit down...another 5 minutes to opening....waiting to BUY MORE...
22/10/2020 8:55 AM
stocktrade101 all vaccine anf glove stocks up la,

https://www.globaltimes.cn/content/1204263.shtml
22/10/2020 9:12 AM
Mynameisntimportant May i know why you guys like dpharma so much? Anything make you think this is beneficial from the cov vaccine, any agreement signed so far? Pleass share link below
22/10/2020 9:17 AM
stocktrade101 it's just hype, nothing special about Malaysia's pharma companies.
22/10/2020 9:19 AM
Godofgambler Going to fly soon!!!
22/10/2020 9:38 AM
stocktrade101 ya, but what's that got to do with dpharma and how much can dpharma make from distributing chinese vaccines (if ever) and are these halal vaccines?
22/10/2020 10:14 AM
taiwengyew Halal is more important or life Is more important? Most of thing is not halal. Our money materials also not Halal also vri
22/10/2020 10:18 AM
bigby7 Aiyoyo... Thanks to whoever that bought my early morning price ya..

My dog will enjoy a good treat..
Tips terang terang bagi tak mau..
22/10/2020 11:21 AM
bigby7 Now is the time to collect at even a lower price.. Time to park my bus low low for all of you. I am a very honest IB
22/10/2020 11:23 AM
Plantermen Vaccines are all classified halal { blood donation} but fill & process production in Malaysia is meant for export to Muslim Arab nations. China has no qualm using Malaysia as a distribution hub. Look at Geely using Proton production hub
22/10/2020 11:30 AM
TenEyeTiger The astra zenica case. The deceased was given a placebo (meningitis vaccine instead of experimental covid 19 vaccine), caught covid 19 in the process and died. Quote:Washington Post

https://www.washingtonpost.com/world/the_americas/coronavirus-oxford-astrazeneca-vaccine-trial-death/2020/10/21/3f5bedac-13c0-11eb-ad6f-36c93e6e94fb_story.html
22/10/2020 11:45 AM
kentrade888 Don't worry about the safety of Chinese vaccines.
22/10/2020 12:12 PM
henry888 Those not comfortable better stay aside/don't buy, don't ask stupid questions ?
22/10/2020 1:20 PM
James89 The Brazilian newspaper O Globo, citing unnamed sources, reported that the volunteer was in a control group that did not receive the experimental vaccine and died of covid-19. The news service G1 said the volunteer was a 28-year-old physician who treated coronavirus patients in Rio de Janeiro.
22/10/2020 1:49 PM
DrJoel88 Time to collect profits for now. Poor vaccine performance in Korea and Brazil. Deaths reported.
22/10/2020 1:58 PM
James89 Deceased AstraZeneca Trial Volunteer Didn’t Receive Vaccine

https://www.google.com.my/amp/s/www.bloomberg.com/amp/news/articles/2020-10-21/astrazeneca-dips-on-report-of-brazil-death-in-vaccine-trial
22/10/2020 5:18 PM
Plantermen Fake news
22/10/2020 7:03 PM
NoNonsenseHere Post removed. Why?
22/10/2020 7:52 PM
NoNonsenseHere Post removed. Why?
22/10/2020 7:54 PM
trade101 Why spamming supermx here??
22/10/2020 8:33 PM
Flytothesky2 https://www.chinapress.com.my/20201022/韩接种流感疫苗-死亡增至10人-皆来自国产疫苗/
23/10/2020 2:36 AM
kukubird88 https://www.cnbc.com/2020/10/22/fda-approves-gileads-remdesivir-as-coronavirus-treatment.html?__source=facebook%7Cmain&fbclid=IwAR12fE5geJyukOozuq5K6guxfw4E8i5OpiG2orlXhffYV6hwYYFaZknCK18
23/10/2020 7:39 AM
stocktrade101 remdesivir is an expensive drug, tedious to apply too. One has to be hospitalized to get treatment.
23/10/2020 8:51 AM
JDinvestor No need to SPAM glove counter information here. Irrelevant.
Admin Please delete them ~
23/10/2020 10:43 AM
foongkitmun Stil some uncertain news about vaccines....this counter might be flat today....
23/10/2020 11:39 AM
henry888 'Muhyiddin chairs a special cabinet meeting'. 3rd clinical covid trials are ongoing, nothing special. Most probably market is cautious about the direction of political.
23/10/2020 1:47 PM
Keyman188 Put more concern on Malaysia uncertainty political issue 1st...

We don't know which party will control the "Administration"...

Don't forget last month during Anwar announcement, what happened for pharmaceutical firm...

https://klse.i3investor.com/servlets/forum/906893457.jsp?fp=2


https://www.sinchew.com.my/content/content_2364143.html
23/10/2020 3:01 PM
FFF888 No one cares, is a GLC not BNLC.
23/10/2020 3:10 PM
henry888 Snap election - no lah...covid....
23/10/2020 4:02 PM
henry888 That is what Z of Umno wanted, the ultimate motive, Ai will never be PM.
23/10/2020 4:03 PM
henry888 Dpharma still ok, KJ is Umno..
23/10/2020 4:06 PM
foongkitmun Hahaha....politic de Dpahrma ka? So wanna sell or not? Down trend ka? No hope?
23/10/2020 4:07 PM
Shin888 什么情况.....
23/10/2020 5:43 PM
pineapple123 The worrying issue about the vaccine which is it will put mankind to prompt HIV infection. This is alarming!

KKM TS Norhisham have come out to warn about the vaccine testing progress yesterday.

It will not do good for Dpharma at this present time.
23/10/2020 7:16 PM
Cklew1832 Habis la ini macam
23/10/2020 7:26 PM
ramunia Don't worry too much.. Norhisham only got the news from overseas. Malaysia doesn't have lab to study or do research, most of the news are from overseas.. China vaccines confirmed can stop the covid 19
.
23/10/2020 7:33 PM
henry888 Chart looks not so nice now for short term because of political issue.
23/10/2020 7:49 PM
pineapple123 Wait and see, since 4.20 can't break it.

Will sideline for a while. I regret didn't see at 4.20 :(((
23/10/2020 7:53 PM
foongkitmun Mon fly to moon ka? Already lock liao ma....so, need to worry ka? Meaning can zzzzz this weekend lo....
23/10/2020 8:03 PM
ramunia Don't worry, my cost is rm 3.3xxx..
23/10/2020 9:09 PM
SHAH NURSYAHMIAIMAN NOOR JALAINI https://www.google.com/amp/s/www.fool.com/amp/investing/2020/10/23/can-a-coronavirus-antibody-knock-out-moderna/
23/10/2020 11:27 PM
Chong1116 https://www.chinapress.com.my/20201020/%e2%97%a4%e5%85%a8%e7%90%83%e5%a4%a7%e6%b5%81%e8%a1%8c%e2%97%a24%e6%ac%be%e7%96%ab%e8%8b%97%e8%be%be3%e6%9c%9f%e4%b8%b4%e5%ba%8a%e9%98%b6%e6%ae%b5-%e4%b8%ad%e5%9b%bd%ef%bc%9a6%e4%b8%87%e4%ba%ba/
24/10/2020 12:00 AM